Temprian Oncology, Inc.
Oak Park, IL
- UEI
- V9F4C7DSFWZ9
- CAGE
- 9HRU4
- SAM.gov registration
- Active through
Company facts
- Self-certified in SAM.gov
- Entity structure
- Corporate Entity (Not Tax Exempt)
- SAM.gov registration date
- Physical address
- 411 N Oak Park Ave #1, Oak Park, IL 60302, USA
Registration and certifications come from SAM.gov and the SBA; company details from public web sources. Updated .
Grant awards
| Award | Agency | Obligated | Awarded |
|---|---|---|---|
| Sttr phase i: monobenzone (mbeh) supercarriers: production and melanoma treatment | National Science Foundation | $295,000 |
Quick answers
Is Temprian Oncology, Inc. registered in SAM.gov?
Yes. Temprian Oncology, Inc.'s SAM.gov registration is active through September 8, 2027.
What is Temprian Oncology, Inc.'s most recent federal award?
Temprian Oncology, Inc.'s most recent federal grant award is Sttr phase i: monobenzone (mbeh) supercarriers: production and melanoma treatment (2327009), from National Science Foundation, on December 1, 2023.
On GovTribe
See Temprian Oncology, Inc.'s full federal record
- Federal grant awards
- Funding analysis by agency, NAICS and set-aside
- Similar vendors